IGF binding protein 2 is a cell-autonomous factor supporting survival and migration of acute leukemia cells

BackgroundThe role of IGF binding protein 2 (IGFBP2) in cancer development is intriguing. Previously we identified IGFBP2 as an extrinsic factor that supports the activity of hematopoietic stem cells (HSCs).Methods and resultsHere we investigated the role of IGFBP2 in in human leukemia cells and in the retroviral AML1-ETO9a transplantation acute myeloid leukemia (AML) mouse model.ResultsIGFBP2 is highly expressed in certain human AML and acute lymphoblastic leukemia (ALL) cells. Inhibition of expression of endogenous IGFBP2 in human leukemia cells led to elevated apoptosis and decreased migration and, consistently, to decreased activation of AKT and other signaling molecules. We also studied the effects of IGFBP2 knockout in the retroviral AML1-ETO9a transplantation AML mouse model. The deletion of IGFBP2 in donor AML cells significantly decreased leukemia development in transplanted mice. Lack of IGFBP2 resulted in upregulation of PTEN expression and downregulation of AKT activation, in the mouse AML cells. The treatment of IGFBP2 deficient AML cells with a PTEN inhibitor restored the wild-type colony forming ability. The deletion of IGFBP2 also led to decreased AML infiltration into peripheral organs and tissues, suggesting that IGFBP2 is required for the migration of AML cells out of bone marrow.ConclusionIGFBP2 is a critical cell-autonomous factor that promotes the survival and migration of acute leukemia cells.

• Publication year

  2013

• Venue

  Journal of Hematology & Oncology

• Publication date

  2013-10-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1186/1756-8722-6-72PMID 24191913PMCID 3851819
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin-like growth factor binding protein 2 (IGFBP-2) promotes growth and survival of breast epithelial cells: novel regulation of the estrogen receptor.

  2013influential reference
• Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression

  2013cited by this paper
• Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-κB network

  2012cited by this paper
• Inhibitory receptors bind Angptls and support blood stem cells and leukemia development

  2012cited by this paper
• IGFBP-2 enhances VEGF gene promoter activity and consequent promotion of angiogenesis by neuroblastoma cells.

  2011cited by this paper
• IGF binding protein 2 supports the survival and cycling of hematopoietic stem cells.

  2011influential reference
• Ex vivo expanded hematopoietic stem cells overcome the MHC barrier in allogeneic transplantation.

  2011cited by this paper
• PML-RARA can increase hematopoietic self-renewal without causing a myeloproliferative disease in mice.

  2011cited by this paper
• IGFBP2 promotes glioma tumor stem cell expansion and survival.

  2010cited by this paper
• Role of insulin-like growth factor binding protein 2 in lung adenocarcinoma: IGF-independent antiapoptotic effect via caspase-3.

  2010cited by this paper
• Insulin-like growth factor binding proteins-2 and -4 enhance the migration of human CD34-/CD133+ hematopoietic stem and progenitor cells.

  2009cited by this paper
• Insulin-like growth factor-binding protein contributes to the proliferation of less proliferative cells in forming skin equivalents.

  2009cited by this paper
• Expression of components of the IGF axis in childhood acute myelogenous leukemia

  2008influential reference
• Insulin‐Like Growth Factor‐Binding Protein 2 Secreted by a Tumorigenic Cell Line Supports Ex Vivo Expansion of Mouse Hematopoietic Stem Cells

  2008cited by this paper
• Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation.

  2008cited by this paper
• Appelbaum FR, Rowe JM, Radich J, Dick JE. Acute Myeloid Leukemia. Hematology Am Soc Hematol Educ Program. 2001:62-86. PMID: 11722979

  2008cited by this paper
• IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells

  2007cited by this paper
• Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer

  2007cited by this paper
• Insulin-like growth factor binding protein 2 promotes glioma development and progression

  2007influential reference
• Silencing of Insulin-like Growth Factor-binding Protein-2 in Human Glioblastoma Cells Reduces Both Invasiveness and Expression of Progression-associated Gene CD24*

  2007cited by this paper
• Insulin-like growth factor binding protein-2 stimulates proliferation and activates multiple cascades of the mitogen-activated protein kinase pathways in NIH-OVCAR3 human epithelial ovarian cancer cells

  2006cited by this paper
• A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis

  2006influential reference
• Insulin-Like Growth Factor Binding Protein-2: Contributions of the C-Terminal Domain to Insulin-Like Growth Factor-1 Binding

  2006cited by this paper
• An Interaction between Insulin-like Growth Factor-binding Protein 2 (IGFBP2) and Integrin α5 Is Essential for IGFBP2-induced Cell Mobility*

  2006influential reference
• Elevated serum insulin-like growth factor binding protein-2 is associated with a high relapse risk after hematopoietic stem cell transplantation in childhood AML

  2006influential reference
• IDENTIFICATION OF NOVEL GENES WITH PROGNOSTIC VALUE IN CHILDHOOD LEUKEMIA USING cDNA MICROARRAY AND QUANTITATIVE RT-PCR

  2006influential reference
• AML1-ETO fusion protein up-regulates TRKA mRNA expression in human CD34+ cells, allowing nerve growth factor-induced expansion.

  2005cited by this paper
• Insulin-like growth factor binding protein-2 at diagnosis of childhood acute lymphoblastic leukemia and the prediction of relapse risk.

  2005influential reference
• Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion.

  2005cited by this paper
• Bimolecular Interaction of Insulin-Like Growth Factor (IGF) Binding Protein-2 with αvβ3 Negatively Modulates IGF-I-Mediated Migration and Tumor Growth 1

  2004cited by this paper
• Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells.

  2004influential reference
• Novel stimulatory role for insulin‐like growth factor binding protein‐2 in prostate cancer cells

  2003cited by this paper
• Changes of serum growth factors (IGF-I,-II and IGFBP-2,-3) prior to and after stem cell transplantation in children with acute leukemia

  2003influential reference
• Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes.

  2003cited by this paper
• Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter?

  2001influential reference
• Acute myeloid leukemia.

  2001cited by this paper
• Distinct patterns of insulin-like growth factor binding protein (IGFBP)-2 and IGFBP-3 expression in oxidant exposed lung epithelial cells.

  2001cited by this paper
• Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions.

  1997cited by this paper
• Functional role of insulin-like growth factor binding proteins.

  1997cited by this paper
• Insulin-like growth factor 2 and insulin-like growth factor binding protein 2 expression in hepatoblastoma.

  1995cited by this paper
• Cell membrane association of insulin-like growth factor binding protein-2 (IGFBP-2) in the rat brain olfactory bulb.

  1995cited by this paper

• IGFBP2 alteration contributes to prostate cancer progression by modulating prostate stroma activation

  2025cites this paper
• Decoding the AML1/ETO Translocation Cipher: In-depth Exploration into the Pathogenesis and Cutting-edge Therapeutic Strategies of t(8;21) Acute Myeloid Leukemia.

  2025cites this paper
• Advances in the role of the IGF signaling system in myelodysplastic syndromes and acute myeloid leukemia

  2025cites this paper
• NIPA1 depletion in tumor-associated macrophages via IGFBP2/EGFR attenuates acute myeloid leukemia progression and chemoresistance

  2025cites this paper
• A machine learning model identifies M3-like subtype in AML based on PML/RARα targets

  2024cites this paper
• Extracellular vesicles from type-2 macrophages increase the survival of chronic lymphocytic leukemia cells ex vivo

  2024cites this paper
• The role of IGF/IGF-1R signaling in the regulation of cancer stem cells

  2024cites this paper
• A novel AML1-ETO/FTO positive feedback loop promotes leukemogenesis and Ara-C resistance via stabilizing IGFBP2 in t(8;21) acute myeloid leukemia

  2024cites this paper
• Several cell-intrinsic effectors drive type I interferon-mediated restriction of HIV-1 in primary CD4+ T cells

  2023cites this paper
• Secreted insulin-like growth factor binding protein 5 functions as a tumor suppressor and chemosensitizer through inhibiting insulin-like growth factor 1 receptor/protein kinase B pathway in acute myeloid leukemia

  2023cites this paper
• Satellite cells sourced from bull calves and dairy cows differs in proliferative and myogenic capacity - Implications for cultivated meat.

  2023cites this paper
• Several cell-intrinsic effectors drive type I interferon-mediated restriction of HIV-1 in primary CD4+ T cells

  2023cites this paper
• Prognostic value of IGFBP2 in various cancers: a systematic review and meta‐analysis

  2022cites this paper
• METTL3 mediates chemoresistance by enhancing AML homing and engraftment via ITGA4

  2022cites this paper
• RHOA-regulated IGFBP2 promotes invasion and drives progression of BCR-ABL1 chronic myeloid leukemia

  2022cites this paper
• Hymeglusin Enhances the Pro-Apoptotic Effects of Venetoclax in Acute Myeloid Leukemia

  2022cites this paper
• Targeting the HIF-1α-IGFBP2 axis therapeutically reduces IGF1-AKT signaling and blocks the growth and metastasis of relapsed anaplastic Wilms tumor

  2021cites this paper
• IGFBP2 in cancer: Pathological role and clinical significance (Review).

  2020cites this paper
• A HIF-1 network reveals characteristics of epithelial-mesenchymal transition_11311-926556_Pattini

  2020cites this paper
• Le rôle des cellules souches mésenchymateuses médullaires dans la leucémie myélomonocytaire chronique

  2019cites this paper
• Gene expression signature that predicts early molecular response failure in chronic-phase CML patients on frontline imatinib.

  2019cites this paper
• [Novel Genes Associated with the Development of Carotid Paragangliomas].

  2019cites this paper
• IGFBP-2 acts as a tumour suppressor and plays a role in determining chemosensitivity in bladder cancer cells

  2019cites this paper
• Novel Genes Associated with the Development of Carotid Paragangliomas

  2019cites this paper
• CAMKs support development of acute myeloid leukemia

  2018cites this paper
• SPG6 supports development of acute myeloid leukemia by regulating BMPR2-Smad-Bcl-2/Bcl-xl signaling.

  2018cites this paper
• Insulin-like growth factor binding protein-2 and its role in angiogenesis

  2018influential citation
• IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma

  2018cites this paper
• Insulin-like growth factor binding protein 2 regulates cell proliferation and migration in the adjuvant arthritis synovial cells through ERK signaling pathway

  2017cites this paper
• Novel Gene and Network Associations Found for Acute Lymphoblastic Leukemia Using Case–Control and Family-Based Studies in Multiethnic Populations

  2017cites this paper
• IGF-binding protein 2 is a candidate target of therapeutic potential in cancer

  2016influential citation
• Sorting protein VPS33B regulates exosomal autocrine signaling to mediate hematopoiesis and leukemogenesis.

  2016cites this paper
• Insulin-Like Growth Factor 2 - The Oncogene and its Accomplices.

  2016cites this paper
• ADCY7 supports development of acute myeloid leukemia.

  2015cites this paper
• IGFBP2 POTENTIATES EGFR-STAT3 SIGNALING IN GLIOMA

  2015cites this paper
• ACER3 supports development of acute myeloid leukemia.

  2015cites this paper
• IGF-IR determines the fates of BCR/ABL leukemia

  2015cites this paper
• Ex vivo expansion of hematopoietic stem cells

  2015cites this paper
• TRIB3 enhances cell viability during glucose deprivation in HEK293-derived cells by upregulating IGFBP2, a novel nutrient deficiency survival factor.

  2015cites this paper
• IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma

  2015influential citation
• A HIF-1 network reveals characteristics of epithelial-mesenchymal transition in acute promyelocytic leukemia

  2014cites this paper
• (Lymph)angiogenic influences on hematopoietic cells in acute myeloid leukemia

  2014cites this paper